These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31031388)

  • 1. Thiocolchicoside associated with epileptic seizures in a chronic hemodialysis patient.
    Yilmaz F; Günen Yılmaz S; Keleş M
    Saudi J Kidney Dis Transpl; 2019; 30(2):513-516. PubMed ID: 31031388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epileptic seizures after treatment with thiocolchicoside.
    De Riu PL; Rosati G; Sotgiu S; Sechi G
    Epilepsia; 2001 Aug; 42(8):1084-6. PubMed ID: 11554898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine partially reverses tonic-clonic seizures induced by thiocolchicoside.
    Leitão DS; Andrade AR; Medeiros NCL; Martins MFC; Ferreira LO; Santos VC; Hamoy AO; Barbas LAL; Muto NA; Jóia de Mello V; Lopes DCF; Hamoy M
    Braz J Med Biol Res; 2022; 55():e11771. PubMed ID: 35239777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporary Seizure in an Infant Who Had Been Exposed to G-Amino Butyric Acid Receptor Antagonist Thiocolchicoside.
    Havali C; Gucuyener K; Gurkas E; Demir E
    Pediatr Emerg Care; 2019 May; 35(5):e96-e97. PubMed ID: 28486264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain.
    Ketenci A; Ozcan E; Karamursel S
    Int J Clin Pract; 2005 Jul; 59(7):764-70. PubMed ID: 15963201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of thiocolchicoside as monotherapy in low back pain. Results of a randomized study versus placebo].
    Marcel C; Rezvani Y; Revel M
    Presse Med; 1990 Jun; 19(24):1133-6. PubMed ID: 2141931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study.
    Cabitza P; Randelli P
    Eur Rev Med Pharmacol Sci; 2008; 12(4):229-35. PubMed ID: 18727454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epileptic seizure after treatment with thiocolchicoside.
    Giavina-Bianchi P; Giavina-Bianchi M; Tanno LK; Ensina LF; Motta AA; Kalil J
    Ther Clin Risk Manag; 2009 Jun; 5(3):635-7. PubMed ID: 19707540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meropenem at recommended dose is a potential risk for seizure in hemodialysis patient.
    Al-Hwiesh A; Alhwiesh A; Abdul-Rahman IS; Al-Harbi A; Mousa D; Skiker S; Abdulkhani A; Beheri H; Radi M; AlKhaldi D; Aldwaihi A; Alqahtani S
    Saudi J Kidney Dis Transpl; 2020; 31(6):1427-1431. PubMed ID: 33565459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefazolin induced seizures in hemodialysis patients.
    Arkaravichien W; Tamungklang J; Arkaravichien T
    J Med Assoc Thai; 2006 Nov; 89(11):1981-3. PubMed ID: 17205885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiocolchicoside: review of adverse effects.
    Prescrire Int; 2016 Feb; 25(168):41-3. PubMed ID: 27042729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency.
    Muruve DA; Steinman TI
    Clin Nephrol; 1996 Jun; 45(6):406-9. PubMed ID: 8793235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Baclofen-associated encephalopathy in a hemodialysis patient with hiccups].
    Quintana LF; Lladó A; Butjosa M; Santamaría J; Torras A; Poch E
    Nefrologia; 2006; 26(4):486-8. PubMed ID: 17058862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Levetiracetam Dosing Regimens in End-Stage Renal Disease Patients Undergoing Intermittent Hemodialysis.
    Shiue HJ; Taylor M; Sands KA
    Ann Pharmacother; 2017 Oct; 51(10):862-865. PubMed ID: 28582998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baclofen Toxicity in Kidney Disease.
    Wolf E; Kothari NR; Roberts JK; Sparks MA
    Am J Kidney Dis; 2018 Feb; 71(2):275-280. PubMed ID: 28899601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal and secondarily generalised convulsive status epilepticus induced by thiocolchicoside in the rat.
    Sechi G; De Riu P; Mameli O; Deiana GA; Cocco GA; Rosati G
    Seizure; 2003 Oct; 12(7):508-15. PubMed ID: 12967581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of thiocolchicoside in Indian patients suffering from low back pain associated with muscle spasm.
    Soonawalla DF; Joshi N
    J Indian Med Assoc; 2008 May; 106(5):331-5. PubMed ID: 18839644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aciclovir and valaciclovir neurotoxicity in patients with renal failure.
    Ruiz-Roso G; Gomis A; Fernández-Lucas M; Díaz-Domínguez M; Teruel-Briones JL; Quereda C
    Nefrologia; 2012; 32(1):114-5. PubMed ID: 22294022
    [No Abstract]   [Full Text] [Related]  

  • 19. The muscle relaxant thiocolchicoside is an antagonist of GABAA receptor function in the central nervous system.
    Carta M; Murru L; Botta P; Talani G; Sechi G; De Riu P; Sanna E; Biggio G
    Neuropharmacology; 2006 Sep; 51(4):805-15. PubMed ID: 16806306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine toxicity in end-stage renal disease patients: a case-control study.
    Solak Y; Atalay H; Biyik Z; Alibasic H; Gaipov A; Guney F; Kucuk A; Tonbul HZ; Yeksan M; Turk S
    Am J Ther; 2014; 21(6):e189-95. PubMed ID: 22874645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.